EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Overview and evaluation of a nationwide hospital-based surveillance system for influenza and COVID-19 in Switzerland (CH-SUR): 2018–2023

Jonathan A Sobel, Marie-Céline Zanella iD, Rebecca Grant, Camille B Valera iD, Maria Suveges, Laura Urbini iD, Khaled Mostaguir, Sara Botero iD, Ursina Roder iD, Davide Bosetti iD, Rami Sommerstein iD, Ulrich Heininger iD und 10 weitere

Swiss Medical Weekly · 2025

DOI: 10.57187/s.4213 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Swiss Medical Weekly, 2025. Verfasst von Jonathan A Sobel und 21 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Global Health, University of Geneva, Geneva, Switzerland. Hauptthemen laut MEDLINE: Influenza, Human, COVID-19, Population Surveillance. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: In 2018, a hospital-based surveillance system for influenza (CH-SUR) was established in six tertiary care hospitals in Switzerland. From March 2020 onwards, this surveillance system was expanded to include more institutions, as well as COVID-19. AIM: To quantitatively evaluate the timeliness and completeness of CH-SUR data and to qualitatively assess stakeholder perceptions of the importance, reliability and adaptability of the surveillance system. METHODS: All patients admitted to one of the participating centres for more than 24 hours and who had a laboratory-confirmed influenza virus or SARS-CoV-2 infection were included in CH-SUR. For all cases, we evaluated the timeliness and completeness of reporting to CH-SUR. A qualitative survey among CH-SUR stakeholders assessed perceived importance, understanding, reliability and adaptability of CH-SUR. RESULTS: Up to 20 centres participated in CH-SUR. Between December 2018 and October 2023, 7375 cases of influenza were reported and between March 2020 and October 2023, 49,235 cases of COVID-19 were reported to CH-SUR. During the COVID-19 pandemic, time to data entry and completeness improved over time; the median delay of data entry in CH-SUR was 5 days (interquartile range [IQR]: 2–23) for COVID-19 and 4 days (IQR: 2–15) for influenza during the period 2018–2023. The completeness of variables was high (99.4%), with the exception of COVID-19 or annual influenza vaccination status (respectively, 15% and 72% “Unknown” responses). Stakeholders perceived the system as important, relevant, understandable and adaptable. CONCLUSION: CH-SUR provided critical epidemiological and clinical information on hospitalised influenza and COVID-19 cases across Switzerland during the pandemic. Our evaluation highlighted the importance and relevance of this system among CH-SUR stakeholders, as well as its importance for preparedness and response to future infectious disease outbreaks.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Influenza, HumanCOVID-19Population SurveillanceHumansSwitzerlandSARS-CoV-2MaleFemaleMiddle AgedAgedPandemicsTertiary Care CentersAdult

Autor:innen und Institutionen

  • Institute of Global Health, University of Geneva, Geneva, Switzerland.
  • Infection Control Programme and WHO Collaborating Centre on Infection Prevention and Control and Antimicrobial Resistance, Geneva University Hospital and Faculty of Medicine, Geneva, Switzerland.
  • Division of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland.
  • Clinical Research Centre, Geneva University Hospitals and Faculty of Medicine, University of Geneva, Geneva, Switzerland.
  • Swiss Federal Office of Public Health, Bern, Switzerland.
  • Faculty of Healthcare Sciences and Medicine, University of Lucerne, Lucerne, Switzerland.

ORCID-Profile: Marie-Céline Zanella, Camille B Valera, Laura Urbini, Sara Botero, Ursina Roder, Davide Bosetti, Rami Sommerstein, Ulrich Heininger, Petra Zimmermann, Peter W Schreiber, Domenica Flury, Anita Niederer-Loher, Philipp Jent, Anne Iten

Zitieren

APA

Sobel, J. A., Zanella, M. C., Grant, R., Valera, C. B., Suveges, M., Urbini, L., Mostaguir, K., Botero, S., Roder, U., Bosetti, D., Sommerstein, R., Heininger, U., Zimmermann, P., Schreiber, P. W., Flury, D., Niederer-Loher, A., Jent, P., Cusini, A., Pittet, D., …, & Keiser, O. (2025). Overview and evaluation of a nationwide hospital-based surveillance system for influenza and COVID-19 in Switzerland (CH-SUR): 2018–2023. Swiss Medical Weekly. https://doi.org/10.57187/s.4213

Vancouver

Sobel JA, Zanella MC, Grant R, Valera CB, Suveges M, Urbini L, et al. Overview and evaluation of a nationwide hospital-based surveillance system for influenza and COVID-19 in Switzerland (CH-SUR): 2018–2023. Swiss Medical Weekly. 2025. doi:10.57187/s.4213

BibTeX
@article{Sobel2025,
  author = {Sobel, Jonathan A and Zanella, Marie-Céline and Grant, Rebecca and Valera, Camille B and Suveges, Maria and Urbini, Laura and Mostaguir, Khaled and Botero, Sara and Roder, Ursina and Bosetti, Davide and Sommerstein, Rami and Heininger, Ulrich and Zimmermann, Petra and Schreiber, Peter W and Flury, Domenica and Niederer-Loher, Anita and Jent, Philipp and Cusini, Alexia and Pittet, Didier and Harbarth, Stephan and Iten, Anne and Keiser, Olivia},
  title = {Overview and evaluation of a nationwide hospital-based surveillance system for influenza and COVID-19 in Switzerland (CH-SUR): 2018–2023},
  journal = {Swiss Medical Weekly},
  year = {2025},
  doi = {10.57187/s.4213}
}
Kostenlos starten →